HONG KONG – China is raising the standard of its generics products in a move to help made-in-China drugs grab a larger share of the global market. As part of that process, however, industry observers expect that more than half of the drugs that are currently sold in the market will be eliminated.
HONG KONG – China is raising the standard of its generics products in a move to help made-in-China drugs grab a larger share of the global market. As part of that process, however, industry observers expect that more than half of the drugs that are currently sold in the market will be eliminated.
HONG KONG – In a move to improve its drug manufacturing, research and development capacity as well as to strengthen its international presence, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. made an offer to acquire a 96 percent stake in Indian drugmaker Gland Pharma Ltd.
HONG KONG – In a move to improve its drug manufacturing, research and development capacity as well as to strengthen its international presence, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. made an offer to acquire a 96 percent stake in Indian drugmaker Gland Pharma Ltd.
HONG KONG – India’s dependence on China for pharmaceutical raw materials is threatening the country’s health care industry and pushing the government to take action.
HONG KONG – Taking another step to strengthen its presence in the promising Chinese market, South Korea-based Hanmi Science Co. Ltd. (KS:008930) will pour about $200 million into a new plant in the fast growing neighboring market.
